Inov8 Presents Further Evidence on the Reduction of Infection Rates in NHS Hospitals Using the AD (Air Disinfection) Technology
Inov8 has commissioned trials at several UK NHS hospitals, as well as overseas hospitals which show the effectiveness of the AD (Air Disinfection) technology against most microoganisms responsible for Healthcare Associated Infections (HCAI).
(PRWeb UK) December 7, 2010
Inov8 Science Ltd, the wholly owned subsidiary of the AIM listed company Mid-States plc, participated in the 7th international conference of the Hospital Infection Society held in Liverpool during October 2010.
The conference takes place every four years and is recognised as the major international conference, focusing on infection prevention and control. It attracts leading world experts in healthcare associated infections as speakers and delegates.
Among the topics discussed was the increasing concern with the prevalence of superbugs such as MRSA, as well as other infectious microorganisms such as Clostridium difficile (C. diff) and Norovirus. Inov8 commissioned trials at several UK NHS hospitals, as well as overseas hospitals. These have shown the effectiveness of the AD (Air Disinfection) technology against most microoganisms responsible for Healthcare Associated Infections (HCAI).
At the conference, Dr Abdel Ezbiri, Inov8’s Chief Scientific Officer presented evidence from trials at the London Royal Free Hospital, the Royal Worcester Hospital and the Redditch Alexandra Hospital. Explaining the results, Dr Ezbiri commented, “The evidence from the Royal Free Hospital clearly demonstrates that the AD can help to significantly reduce environmental surface TVCs and MRSA by up 22% and 83% respectively. In the cases of the Royal Worcester Hospital and the Redditch Alexandra Hospital, the AD not only helped to significantly reduce environmental air TVCs, but it also showed a good correlation between the TVC curve and patients’ infection rate curve for the same period.”
Attendees at the conference were impressed by the simplicity and efficacy of the Inov8 air disinfection system and how it helps to prevent the airborne spread of a wide range of viruses, bacteria and fungi. The AD provides continuous air disinfection with hydroxyl radicals at levels that mimic atmospheric concentrations which are harmless to humans but extremely effective against bacteria and viruses.
Inov8’s AD system is a winner in the 2009 Smart Solutions Programme for the UK NHS. The system is already in use in clinics and hospitals throughout the world. Inov8 continues to expand internationally through the appointment of specialist distributors.
###
